Deutsche Bank’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.75M | Sell |
|
|||||
|
2025
Q2 | $1.43M | Buy |
|
|||||
|
2025
Q1 | $1.41M | Hold |
|
|||||
|
2024
Q4 | $2.29M | Hold |
|
|||||
|
2024
Q3 | $1.06M | Hold |
|
|||||
|
2024
Q2 | $1.02M | Sell |
|
|||||
|
2024
Q1 | $1.19M | Buy |
|
|||||
|
2023
Q4 | $981K | Buy |
|
|||||
|
2023
Q3 | $1.06M | Sell |
|
|||||
|
2023
Q2 | $11.3M | Sell |
|
|||||
|
2023
Q1 | $8.92M | Sell |
|
|||||
|
2022
Q4 | $18.5M | Buy |
|
|||||
|
2022
Q3 | $18.4M | Sell |
|
|||||
|
2022
Q2 | $16.4M | Sell |
|
|||||
|
2022
Q1 | $25.3M | Buy |
|
|||||
|
2021
Q4 | $3.69M | Sell |
|
|||||
|
2021
Q3 | $5.8M | Sell |
|
|||||
|
2021
Q2 | $5.87M | Buy |
|
|||||
|
2021
Q1 | $6.52M | Buy |
|
|||||
|
2020
Q4 | $425K | Hold |
|
|||||
|
2020
Q3 | $169K | Hold |
|
|||||
|
2020
Q2 | $106K | Buy |
|
|||||
|
2020
Q1 | $41K | Sell |
|
|||||
|
2019
Q4 | $73K | Buy |
|
|||||
|
2019
Q3 | $9K | Sell |
|
|||||
|
2019
Q2 | $992K | Buy |
|
|||||
|
2019
Q1 | $522K | Buy |
|
|||||
|
2018
Q4 | $442K | Sell |
|
|||||
|
2018
Q3 | $4.7M | Buy |
|
|||||
|
2018
Q2 | $4.58M | Buy |
|
|||||
|
2018
Q1 | $1.71M | Sell |
|
|||||
|
2017
Q4 | $4.43M | Buy |
|
|||||
|
2017
Q3 | $3.58M | Buy |
|
|||||
|
2017
Q2 | $3.24M | Buy |
|
|||||
|
2017
Q1 | $2.69M | Sell |
|
|||||
|
2016
Q4 | $2.99M | Buy |
|
|||||
|
2016
Q3 | $1.32M | Buy |
|
|||||
|
2016
Q2 | $671K | Buy |
|
|||||
|
2016
Q1 | $16K | Sell |
|
|||||
|
2015
Q4 | $38K | Buy |
|